Ecstasy named 'breakthrough therapy' for PTSD
MDMA therapy could be rolled out for US Army after successful trial

Ecstasy could soon be used to treat soldiers suffering from Post Traumatic Stress Disorder (PTSD) after a "breakthrough" trial conducted by the US Army trial was hailed by both scientists and the military.
MDMA, the active compound in ecstasy, is "emerging as the most promising tool to come along in years for the military's escalating PTSD epidemic", says the Washington Post.
Initially ridiculed, the tests have been so successful that the Food and Drug Administration, the US drug regulator, has classed the drug a "breakthrough therapy" - setting it on a fast track for review and potential approval for mass use.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It is estimated that that between 10 and 20 per cent of all soldiers who served in Iraq or Afghanistan suffer from PTSD, typically triggered by experiencing or witnessing violence, and often leading to severe panic attacks or a nervous breakdown.
Currently only two drugs are approved for treating the affliction but "both have proved largely ineffective when it comes to veterans, whose cases are especially difficult to resolve because of their prolonged or repeated exposure to combat", says The Independent.
Following the success of the MDMA trial, the prospect of a government-sanctioned psychedelic drug has generated "both excitement and concern", says the Post, with many military and government leaders hesitant to embrace the use of what are usually illegal drugs.
However, given the growing severity of the PTSD problem it could be that medical necessity trumps their objections.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Slovenia is ready for its moment in the travel spotlight
The Week Recommends Mountains, lakes, caves and coastline await
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
'Haiti's crisis is a complex problem that defies solution'
Instant Opinion Opinion, comment and editorials of the day
-
Is Europe's defence too reliant on the US?
Today's Big Question As the UK and EU plan to 're-arm', how easy will it be to disentangle from US equipment and support?
-
How US involvement in Vietnam War influenced foreign policy decisions for 50 years
feature Lessons from the Vietnam War remain prism through which US views armed conflicts
-
Is Henry Kissinger right about Ukraine?
Speed Read The US statesman made a controversial speech at a virtual Davos appearance last week
-
Volodymyr Zelenskyy refused evacuation as Russian hitmen ‘parachuted’ into Kyiv
Speed Read Ukrainian president turned down opportunity to leave capital despite threat to life, adviser claims
-
America’s withdrawal from Afghanistan: a retreat into isolationism?
Speed Read ‘In his selfish unilateralism’, Biden is no better than Trump, said The Daily Telegraph
-
The ‘heat dome’: blistering temperatures in the Pacific Northwest should act as a wake-up call
Speed Read People are used to hearing of record-high temperatures in desert states such as Nevada or Arizona, but not in verdant Washington and Oregon
-
Royal Marines ready to ‘disrupt and confuse’ enemies
Speed Read Military chief says operating in area between peace and war could prevent all-out conflict
-
US Secret Service screening inauguration troops for riot sympathisers
Speed Read National Guard members under investigation as mob member claims GOP lawmakers aided Capitol siege